Changes in glutamate decarboxylase enzyme activity and tau-protein phosphorylation in the hippocampus of old rats exposed to chronic mild stress: Reversal with the neuronal nitric oxide synthase inhibitor 7-nitroindazole

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 3, 2009, Pages 339-344

  El faramawy, Yasser A ^a   El banouby, Mohamed H ^a   Sergeev, Pavel ^c   Mortagy, Ahmed K ^a   Amer, Motassem S ^a   Abdel tawab, Ahmed M ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Ain Shams University   (Egypt)

^c ETH ZURICH   (Switzerland)

Author keywords

7 nitroindazole; Chronic mild stress; Glutamate decarboxylase enzyme; Hippocampus; Old rats; tau protein phosphorylation

Indexed keywords

7 NITROINDAZOLE; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TAU PROTEIN;

AGE; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CHRONIC STRESS; CONTROLLED STUDY; ENZYME ACTIVITY; EXPOSURE; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

AGING; ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; ENZYME INHIBITORS; FEEDING BEHAVIOR; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; HIPPOCAMPUS; INDAZOLES; MALE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE I; PHOSPHORYLATION; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; TAU PROTEINS;

RATTUS; RATTUS NORVEGICUS;

EID: 57449120921     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.08.003     Document Type: Article

References (62)

1. Anisman H., and Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 29 (2005) 525-546
2. Avila J., Lucas J.J., Perez M., and Hernandez F. Role of tau protein in both physiological and pathological conditions. Physiol Rev 84 (2004) 361-384
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
4. Brewer G.J. Age-related toxicity to lactate, glutamate, and beta-amyloid in cultured adult neurons. Neurobiol Aging 19 (1998) 561-568
5. Buée-Scherrer V., and Goedert M. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases in intact cells. FEBS Lett 515 (2002) 151-154
6. Chakraborty M., Lahiri P., Anderson G.M., and Chatterjee D. Use of high-performance liquid chromatography for assay of glutamic acid decarboxylase. Its limitation in use for post-mortem brain. J Chromatogr 571 (1991) 235-240
7. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 52 (1996) 597-617
8. Colton C.A., Brown C.M., Czapiga M., and Vitek M.P. Apolipoprotein-E allele-specific regulation of nitric oxide production. Ann N Y Acad Sci 962 (2002) 212-225
9. Dalla C., Antoniou K., Drossopoulou G., Xagoraris M., Kokras N., Sfikakis A., et al. Chronic mild stress impact: are females more vulnerable?. Neuroscience 135 (2005) 703-714
10. Echeverry M.B., Guimaraes F.S., and Del Bel E.A. Acute and delayed restraint stress-induced changes in nitric oxide producing neurons in limbic regions. Neuroscience 125 (2004) 981-993
11. Ferrari E., Cravello L., Muzzoni B., Casarotti D., Paltro M., Solerte S.B., et al. Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 144 (2001) 319-329
12. Firk C., and Markus C.R. Serotonin by stress interaction: a susceptibility factor for the development of depression?. J Psychopharmacol 21 5 (2007) 538-544
13. Galimberti D., Venturelli E., Gatti A., Lovati C., Fenoglio C., Mariani C., et al. Association of neuronal nitric oxide synthase C276T polymorphism with Alzheimer's disease. J Neurol 252 (2005) 985-986
14. Goedert M., Hasegawa M., Jakes R., Lawler S., Cuenda A., and Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 409 (1997) 57-62
15. Green K.N., Billings L.M., Roozendaal B., McGaugh J.L., and LaFerla F.M. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26 (2006) 9047-9056
16. Grønli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., et al. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav Brain Res 181 (2007) 42-51
17. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83 (1986) 4913-4917
18. Gunawan S., Walton N.Y., and Treiman D.M. High-performance liquid chromatographic determination of selected amino acids in rat brain by precolumn derivatization with phenylisothiocyanate. J Chromatogr 503 (1990) 177-187
19. Harkin A.J., Bruce K.H., Craft B., and Paul I.A. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 372 (1999) 207-213
20. Herman J.P., and Larson B.R. Differential regulation of forebrain glutamic acid decarboxylase mRNA expression by aging and stress. Brain Res 912 (2001) 60-66
21. Herman J.P., Larson B.R., Speert D.B., and Seasholtz A.F. Hypothalamo-pituitary-adrenocortical dysregulation in aging F344/Brown-Norway F1 hybrid rats. Neurobiol Aging 22 (2001) 323-332
22. Hsu C.C., Thomas C., Chen W., Davis K.M., Foos T., Chen J.L., et al. Role of synaptic vesicle proton gradient and protein phosphorylation on ATP-mediated activation of membrane-associated brain glutamate decarboxylase. J Biol Chem 274 (1999) 24366-24371
23. Jäsmä A., Backstrom A., Gustafsson E., Dehvari N., Hiller G., Cowburn R.F., et al. Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells. Biochem Biophys Res Commun 345 (2006) 324-331
24. Jayatissa M.N., Bisgaard C., Tingström A., Papp M., and Wiborg O. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 31 11 (2006) 2395-2404
25. Jayatissa M.N., Bisgaard C.F., West M.J., and Wiborg O. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 54 3 (2008) 530-541
26. Jeong Y.H., Park C.H., Yoo J., Shin K.Y., Ahn S.M., Kim H.S., et al. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model. FASEB J 20 (2006) 729-731
27. Joca S.R., and Guimaraes F.S. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology (Berl) 185 (2006) 298-305
28. Kannurpatti S.S., Sanganahalli B.G., Mishra S., Joshi P.G., and Joshi N.B. Glutamate-induced differential mitochondrial response in young and adult rats. Neurochem Int 44 (2004) 361-369
29. Keil U., Bonert A., Marques C.A., Scherping I., Weyermann J., Strosznajder J.B., et al. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 279 (2004) 50310-50320
30. Korneyev A.Y. Stress-induced tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity. Neurochem Res 23 (1998) 1539-1543
31. Lahiri D.K., Chen D., Ge Y.W., Farlow M., Kotwal G., Kanthasamy A., et al. Does nitric oxide synthase contribute to the pathogenesis of Alzheimer's disease?: effects of beta-amyloid deposition on NOS in transgenic mouse brain with AD pathology. Ann N Y Acad Sci 1010 (2003) 639-642
32. Luth H.J., Ogunlade V., Kuhla B., Kientsch-Engel R., Stahl P., Webster J., et al. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex 15 (2005) 211-220
33. McEwen B.S. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci 933 (2001) 265-277
34. McEwen B.S. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 54 (2005) 20-23
35. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87 (2007) 873-904
36. Meyer R.C., Spangler E.L., Patel N., London E.D., and Ingram D.K. Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur J Pharmacol 341 (1998) 17-22
37. Moreno-Lopez B., Romero-Grimaldi C., Noval J.A., Murillo-Carretero M., Matarredona E.R., and Estrada C. Nitric oxide is a physiological inhibitor of neurogenesis in the adult mouse subventricular zone and olfactory bulb. J Neurosci 24 (2004) 85-95
38. Okawa Y., Ishiguro K., and Fujita S.C. Stress-induced hyperphosphorylation of tau in the mouse brain. FEBS Lett 535 (2003) 183-189
39. Ownby R.L., Crocco E., Acevedo A., John V., and Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63 (2006) 530-538
40. Patel J.R., and Brewer G.J. Age-related changes in neuronal glucose uptake in response to glutamate and beta-amyloid. J Neurosci Res 72 (2003) 527-536
41. Paul I.A., and Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003 (2003) 250-272
42. Pietrzik C., and Behl C. Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application. Int J Exp Pathol 86 (2005) 173-185
43. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149 (1992) 999-1010
44. Rameau G.A., Tukey D.S., Garcin-Hosfield E.D., Titcombe R.F., Misra C., Khatri L., et al. Biphasic coupling of neuronal nitric oxide synthase phosphorylation to the NMDA receptor regulates AMPA receptor trafficking and neuronal cell death. J Neurosci 27 (2007) 3445-3455
45. Ringheim G.E., and Szczepanik A.M. Brain inflammation, cholesterol, and glutamate as interconnected participants in the pathology of Alzheimer's disease. Curr Pharm Des 12 (2006) 719-738
46. Rissman R.A., Lee K.F., Vale W., and Sawchenko P.E. Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. J Neurosci 27 (2007) 6552-6562
47. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316 (2007) 750-754
48. Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48 (2000) 755-765
49. Soghomonian J.J., and Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol Sci 19 (1998) 500-505
50. Sommer D., Coleman S., Swanson S.A., and Stemmer P.M. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch Biochem Biophys 404 (2002) 271-278
51. Tafet G.E., and Smolovich J. Psychoneuroendocrinological studies on chronic stress and depression. Ann N Y Acad Sci 1032 (2004) 276-278
52. Thorns V., Hansen L., and Masliah E. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp Neurol 150 (1998) 14-20
53. Watts J., Fowler L., Whitton P.S., and Pearce B. Release of arginine, glutamate and glutamine in the hippocampus of freely moving rats: involvement of nitric oxide. Brain Res Bull 65 6 (2005) 521-528
54. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52 (2005) 90-110
55. Willner P., Muscat R., and Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16 (1992) 525-534
56. Wilson R.S., Barnes L.L., Mendes de Leon C.F., Aggarwal N.T., Schneider J.S., Bach J., et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 59 (2002) 364-370
57. Wragg R.E., and Jeste D.V. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 146 (1989) 577-587
58. Yew D.T., Wong H.W., Li W.P., Lai H.W., and Yu W.H. Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains. Neuroscience 89 (1999) 675-686
59. Yoshida H., Hastie C.J., McLauchlan H., Cohen P., and Goedert M. Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). J Neurochem 90 (2004) 352-358
60. Zarate Jr. C.A., Du J., Quiroz J., Gray N.A., Denicoff K.D., Singh J., et al. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann N Y Acad Sci 1003 (2003) 273-291
61. Zhou Q.G., Hu Y., Hua Y., Hu M., Luo C.X., Han X., et al. Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis. J Neurochem. 103 5 (2007) 1843-1854
62. Zhu X.J., Hua Y., Jiang J., Zhou Q.G., Luo C.X., Han X., et al. Neuronal nitric oxide synthase-derived nitric oxide inhibits neurogenesis in the adult dentate gyrus by down-regulating cyclic AMP response element binding protein phosphorylation. Neuroscience 141 (2006) 827-836